Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18).

AUTOR(ES)

Ueda, T

RESUMO

The divalent cation-dependent interaction of the beta 2 integrin CR3 (CD11b/CD18) with the major complement opsonic C3 fragment iC3b is an important component of the central role of CR3 in inflammation and immune clearance. In this investigation we have identified the iC3b binding site in CR3. A recombinant fragment representing the CR3 A-domain, a 200-amino acid region in the ectodomain of the CD11b subunit, bound to iC3b directly and in a divalent cation-dependent manner. The iC3b binding site was further localized to a short linear peptide that also bound iC3b directly and inhibited iC3b binding to the A-domain as well as to CR3 expressed by human neutrophils. These data establish a major recognition function for the integrin A-domain and have important implications for development of novel antiinflammatory therapeutics.

Documentos Relacionados

• Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent.
• Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
• Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18.
• Ca ions stabilize the binding of complement factor iC3b to the pseudohyphal form of Candida albicans.
• Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.